These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27213797)

  • 1. [Significance of laser confocal tomography in diagnosis and monitoring of keratoconjunctivitis sicca].
    Safonova TN; Gladkova ОV; Boev VI
    Vestn Oftalmol; 2016; 132(2):47-54. PubMed ID: 27213797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy].
    Safonova TN; Gladkova OV; Boev VI; Fedorov AA
    Vestn Oftalmol; 2016; 132(5):39-48. PubMed ID: 27911424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New approaches to the treatment of keratoconjunctivitis sicca].
    Safonova TN; Gladkova OV; Novikov IA; Boev VI; Fedorov AA
    Vestn Oftalmol; 2017; 133(2):75-81. PubMed ID: 28524144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of Langerhans Cells in the Central Cornea as Tool for Monitoring Inflammatory Changes in Patients with Keratoconjunctivitis sicca under Topical Therapy with Cyclosporine A 0.05% Eye Drops].
    Schneider E; Paulsen F; Jacobi C
    Klin Monbl Augenheilkd; 2020 May; 237(5):669-674. PubMed ID: 32434251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
    Kaswan RL; Salisbury MA; Ward DA
    Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxidative stress correction in the treatment of severe keratoconjunctivitis sicca in patients with Sjorgen's syndrome].
    Safonova TN; Gladkova OV; Boev VI
    Vestn Oftalmol; 2019; 135(1):59-66. PubMed ID: 30830076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topical cyclosporine for the treatment of ocular surface changes in contact lens wearers].
    Egorova GB; Mitichkina TS; Fedorov AA; Shamsudinova AR
    Vestn Oftalmol; 2015; 131(1):36-42. PubMed ID: 25872385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K; Balicki I; Szadkowski M
    Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.
    Malhotra R; Devries DK; Luchs J; Kabat A; Schechter BA; Shen Lee B; Shettle L; Smyth-Medina R; Ogundele A; Darby C; Bacharach J; Karpecki P
    Cornea; 2019 Oct; 38(10):1259-1265. PubMed ID: 31306284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the preoperative use of artificial tears combined with recombinant bovine basic fibroblast growth factor on cataract patients complicated with dry eyes.
    Xiao W; Huang P
    Arq Bras Oftalmol; 2022; 87(2):0539. PubMed ID: 36169441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca].
    Schrell C; Cursiefen C; Kruse F; Jacobi C
    Klin Monbl Augenheilkd; 2012 May; 229(5):548-53. PubMed ID: 22189827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of an artificial substitute to improve corneal sensitivity in glaucomatous patients on chronic therapy with prostaglandin analogs.
    Vagge A; Bonino M; Rolando M; Macrì A; Traverso CE; Iester M
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):286-90. PubMed ID: 25974240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Color discrimination in patients with keratoconjunctivitis sicca before and after artificial tear application.
    Rieger G
    Wien Klin Wochenschr; 1998 Apr; 110(8):296-7. PubMed ID: 9615962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tear film osmolarity using the TearLab
    Sebbag L; Park SA; Kass PH; Maggs DJ; Attar M; Murphy CJ
    Vet Ophthalmol; 2017 Jul; 20(4):357-364. PubMed ID: 27761982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the effect of cyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation following cataract surgery.
    Hamada S; Moore TC; Moore JE; Al-Dreihi MG; Anbari A; Shah S
    Cont Lens Anterior Eye; 2016 Feb; 39(1):15-9. PubMed ID: 26275686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic power of the tests for tear gland related keratoconjunctivitis sicca.
    Klaassen-Broekema N; Mackor AJ; van Bijsterveld OP
    Neth J Med; 1992 Apr; 40(3-4):113-6. PubMed ID: 1603200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.